Search

everythinglearnresearchcommunity

for

Search:↓

CD34 is crucial for skin tumor development in mice.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

QLT0267 stops hair follicle cell growth and movement.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

A young man was unexpectedly diagnosed with basal cell carcinoma after a scalp examination and confocal microscopy.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Epidermal cysts come from the skin, while pilar cysts come from hair follicles.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

A unique hair tumor with a rippled pattern was identified, showing incomplete differentiation and unusual cell arrangements.

Injecting CD34+ cell-containing platelet-rich plasma into the scalp can improve hair count and thickness in people with pattern hair loss.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

S100A3 protein is mainly found in specific parts of human hair cells.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

AgK114 protein helps in hamster skin injury recovery.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.